sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 4-Amino-4h-1,2,4-triazole-3-thiol

4-Amino-4h-1,2,4-triazole-3-thiol

CAS No.:
4343-75-3
Catalog Number:
AG0039R9
Molecular Formula:
C2H4N4S
Molecular Weight:
116.1450
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$179
- +
Product Description
Catalog Number:
AG0039R9
Chemical Name:
4-Amino-4h-1,2,4-triazole-3-thiol
CAS Number:
4343-75-3
Molecular Formula:
C2H4N4S
Molecular Weight:
116.1450
MDL Number:
MFCD00128280
IUPAC Name:
4-amino-1H-1,2,4-triazole-5-thione
InChI:
InChI=1S/C2H4N4S/c3-6-1-4-5-2(6)7/h1H,3H2,(H,5,7)
InChI Key:
DLLBXBCKFUPBJE-UHFFFAOYSA-N
SMILES:
Nn1cn[nH]c1=S
NSC Number:
156612
Properties
Complexity:
119  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
116.016g/mol
Formal Charge:
0
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
116.142g/mol
Monoisotopic Mass:
116.016g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
85.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.8  
Literature
Title Journal
(E)-4-{[(3-Propyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-4-yl)imino]-meth-yl}-3-(p-tol-yl)-1,2,3-oxadiazol-3-ium-5-olate. Acta crystallographica. Section E, Structure reports online 20111001
Synthesis, antimicrobial evaluation and QSAR analysis of novel nalidixic acid based 1,2,4-triazole derivatives. European journal of medicinal chemistry 20110901
Synthesis and molluscicidal evaluation of some new pyrazole, isoxazole, pyridine, pyrimidine, 1,4-thiazine and 1,3,4-thiadiazine derivatives incorporating benzofuran moiety. European journal of medicinal chemistry 20101101
Some bivalent metal complexes of Schiff bases containing N and S donor atoms. Journal of enzyme inhibition and medicinal chemistry 20061201
Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives. Acta poloniae pharmaceutica 20040101
Properties